Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | PRKCA | P17252 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9515975 | 0.78 | ABCB1 (0.37) | TDP1ARGAA | |
| SCHEMBL1359798 | 0.78 | LMNA (0.38) | TDP1ARGAA | |
| SCHEMBL4927394 | 0.77 | LMNA (0.38) | TDP1 | |
| SCHEMBL8378374 | 0.77 | LMNA (0.34) | TDP1 | |
| SCHEMBL8377049 | 0.77 | LMNA (0.36) | TDP1 | |
| SCHEMBL8374414 | 0.76 | LMNA (0.34) | TDP1 | |
| SCHEMBL28880448 | 0.76 | LMNA (0.36) | TDP1AR | |
| SCHEMBL7594178 | 0.75 | TDP1 (0.37) | TDP1ARGAAPRKCA | |
| SCHEMBL8764396 | 0.75 | ABCB1 (0.32) | — | |
| SCHEMBL8063052 | 0.75 | LMNA (0.36) | TDP1AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1792894-B1 | Contrast agents | GE HEALTHCARE AS (NO) | 2010-09-22 | — | — | EP | disclosed |
| US-7485753-B2 | Contrast agents | GE HEALTHCARE AS (NO) | 2009-02-03 | — | — | US | disclosed |
| US-20080199402-A1 | Contrast Agents | GE HEALTHCARE AS (NO) | 2008-08-21 | — | — | US | disclosed |
| EP-1792894-A2 | Contrast agents | GE Healthcare AS (NO) | 2007-06-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080199402-A1 | Contrast Agents | PYM1, MIA3, IPO11 | TDP1 2302/4885AR 4022/4885GAA 4385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.